Key facts
- imd BIOTECH’s last known valuation is $8.0M (May 2024).
- It has raised $2.1M; the latest was Seed Round ($5.9M) in Jan 2026.
- Notable investors include Superangels, Austria Wirtschaftsservice, CK Venture Capital, Gernot Rericha, Nikolaus Futter — 7 tracked in total.
- Status: Privately Held (backing).
- ·The complete investor list — 7 names
- ·Watchlist + deal alerts for imd BIOTECH
- ·The full record, as it builds
Funding rounds
No funding rounds for imd BIOTECH are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About imd BIOTECH
Developer of a next-generation food pathogen identification technology designed to eliminate the trade-off between accuracy and speed in food safety testing. The company offers real-time bacterial growth detection without external enrichment and a simplified one-step preparation workflow, enabling food producers and safety labs to make faster and more informed decisions.
- Sector
- Materials and Resources
- HQ
- Vienna, Austria
- Founded
- 2021
- Employees
- 13
- Website
- imdbiotech.com/
- Ownership
- Privately Held (backing)
imd BIOTECH doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in imd BIOTECH shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on imd BIOTECH in its N-PORT filings yet. We sweep new filings monthly.